WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by ...

(Investor Share Class) underperformed the benchmark, the S&P 500 Index, for the quarter, but outperformed the benchmark since ...

SOL surges past $191 as analysts flag bullish breakout potential, $11 million in liquidated shorts, and $39 million in weekly institutional inflows.

I want to eat” popped up in Chinese characters on a computer at a public hospital in central Beijing. The words were formed ...

Harvard University was back in court Monday for a major hearing in its funding fight case against the Trump administration, ...

Unlike social media, AI could help bring people together IRL, especially in the still-untapped realm of multiplayer ...

It has supported 800 businesses across the region, with funding from the Bank expected to generate £400m in additional ...

While press releases flood newsrooms with AI celebration messaging, research shows enterprise deployment is deepening ...

A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

An independent report stresses the need for state oversight and a strong nonprofit arm as the company tries to convert to a ...

An advisory board convened by OpenAI says it should continue to be controlled by a nonprofit because the artificial ...

Lobby groups say the money freed up for technology under the budget proposal isn't enough. View on euronews ...